Alterations in lymphocyte subset patterns and co-stimulatory molecules in patients with Alzheimer disease

Chinese Medical Journal

Volumn 122, Issue 12, 2009, Pages 1469-1472

  Xue, Shou Ru ^a   Xu, Dong Hua ^a   Yang, Xin Xin ^a   Dong, Wan Li ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Alzheimer disease; Costimulatory molecule; Lymphocytes

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; HLA DR ANTIGEN;

AGED; ALZHEIMER DISEASE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; NATURAL KILLER CELL; T LYMPHOCYTE SUBPOPULATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIGENS, CD28; ANTIGENS, CD80; B-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; T-LYMPHOCYTE SUBSETS;

EID: 68249133572     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.12.022     Document Type: Article

References (15)

1. McGeer PL, McGeer FG. Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging 2001; 22: 799-809.
2. Tan J, Town T, Abdullah L, Wu Y, Placzek A, Small B, et al. CD45 isoform alteration in CD4 T-cells as a potential diagnosis marker of Alzheimer's disease. J Neuroimmunol 2002; 132: 164-172.
3. Wyss-coray T, Mucke L. Inflammation in neurodegenerative disease - a double-edged sword. Neuron 2002; 35: 419-432.
4. Speciale L, Calabrese E, Saresella M, Tinelli C, Mariani C, Sanvito L, et al. Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients. Neurobiol Aging 2007; 9: 1163-1169.
5. Reale M, Iarlori C, Gambi F, Feliciani C, Salone A, Toma L, et al. Treatment with acetylcholinesterase inhibition in Alzheimer's patients modulates the expression and production of the proinflammatory and anti-inflammatory cytokines. J Neuroimmunol 2004; 148: 162-171.
6. Pirttila T, Mattinen S, Frey H. The decrease of CD8-positive lymphocytes in Alzheimer's disease. J Neurol Sci 1992; 170: 160-165.
7. Richartz E, Stransky E, Batra A, Simon P, Lewczuk P, Buchkremer G, et al. Decline of immune responsiveness: a pathogenetic factor in Alzheimer's disease. J Psychiatr Res 2005; 39: 535-543.
8. Giubilei F, Antonini G, Montesperelli C, Sepe-Monti M, Cannoni S, Pichi A, et al. T cell response to amyloid-beta and to mitochondrial antigens in Alzheimer's disease. Dement Geriatr Cogn Disord 2003; 16: 35-38.
9. Zhang J, Kong Q, Zhang Z, Ge P, Ba D, He W. Telomere dysfunction of lymphocytes in patients with Alzheimer's disease. Cogn Behav Neurol 2003; 16: 170-176.
10. Togo T, Akiyama H, Iseki E, Kondo H, Ikeda K, Kato M, et al. Occurrence of T-cells in the brain of Alzheimer's disease and other neurological diseases. J Neuroimmunol 2002; 124: 83-92.
11. + regulatory T-cells I neurodegeneration: a dialogue with microglia. Proc Natl Acad Sci U S A 2004; 101: 14663-14669.
12. Moir RD, Tseitlin KA, Soscia S, Hyman BT, Irizarry MC, Tanzi RE, et al. Autoantibodies to redox-modified oligomeric Abeta are attenuated in the plasma of Alzheimer's disease patients. J Biol Chem 2005; 280: 17458-17463.
13. Ahluwalia N, Vellas B. Immunologic and inflammatory mediators and cognitive decline in AD. Immunol Allergy Clin North Am 2003; 23: 103-115.
14. Martin-Romero C, Santos-Alvarez J, Goberna R, Goberna R, Sanchez-Margalet V. Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol 2000; 199: 15-24.
15. - cytotoxic effector clones. Int Immunol 1999; 11: 229-241.